BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 17, 2008
View Archived Issues
MacroGenics Boosts Anticancer Pipeline with Raven Acquisition
In a deal to be announced Thursday morning, MacroGenics Inc. is bolstering its anticancer antibody pipeline with the acquisition of Raven Biotechnologies Inc. (BioWorld Today)
Read More
Optimer's Prulifloxacin Data Positive in First Phase III Study
Read More
Same Receptor is Helpful, Harmful for HIV Infection
Read More
BioAlliance Stops Doxorubicin Trial After Pulmonary Reactions
Read More
Jazz $26M Stock Sale to Fund Luvox Commercialization
Read More
PTC Gets $25M From Nonprofit to Fund Cystic Fibrosis Studies
Read More
Other News To Note
Read More
Clinic Roundup
Read More